Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.240
-0.030 (-1.32%)
At close: Apr 28, 2026, 4:00 PM EDT
2.306
+0.066 (2.96%)
After-hours: Apr 28, 2026, 7:36 PM EDT
Fortress Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 61.24 | 56.68 | 64.99 | 73.07 | 68.79 | Upgrade
|
| Other Revenue | 2.02 | 1 | 19.52 | 2.67 | - | Upgrade
|
| Revenue | 63.26 | 57.68 | 84.51 | 75.74 | 68.79 | Upgrade
|
| Revenue Growth (YoY) | 9.69% | -31.76% | 11.58% | 10.11% | 50.86% | Upgrade
|
| Cost of Revenue | 32.83 | 77.76 | 128.96 | 165.65 | 160.95 | Upgrade
|
| Gross Profit | 30.44 | -20.09 | -44.45 | -89.91 | -92.16 | Upgrade
|
| Selling, General & Admin | 96.4 | 87.73 | 87.84 | 113.66 | 86.84 | Upgrade
|
| Amortization of Goodwill & Intangibles | 4.26 | 3.42 | 3.77 | - | - | Upgrade
|
| Other Operating Expenses | - | -4.55 | - | - | - | Upgrade
|
| Operating Expenses | 100.66 | 86.6 | 91.61 | 113.66 | 86.84 | Upgrade
|
| Operating Income | -70.22 | -106.69 | -136.06 | -203.56 | -179 | Upgrade
|
| Interest Expense | -10.11 | -9.93 | -15.32 | -13.64 | -15.31 | Upgrade
|
| Interest & Investment Income | 2.49 | 2.68 | 3 | 1.4 | 0.65 | Upgrade
|
| Other Non Operating Income (Expenses) | 32.28 | 0.68 | 1.02 | 2.34 | -0.45 | Upgrade
|
| EBT Excluding Unusual Items | -45.56 | -113.25 | -147.35 | -213.46 | -194.11 | Upgrade
|
| Gain (Loss) on Sale of Investments | -15.1 | - | - | - | 39.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | 27.13 | - | - | - | - | Upgrade
|
| Asset Writedown | - | -3.69 | -6.29 | - | - | Upgrade
|
| Other Unusual Items | - | -3.6 | - | - | -9.54 | Upgrade
|
| Pretax Income | -33.54 | -120.54 | -153.63 | -213.46 | -164.35 | Upgrade
|
| Income Tax Expense | -0.62 | 0.31 | 0.52 | 0.45 | 0.47 | Upgrade
|
| Earnings From Continuing Operations | -32.92 | -120.86 | -154.15 | -213.91 | -164.83 | Upgrade
|
| Net Income to Company | -32.92 | -120.86 | -154.15 | -213.91 | -164.83 | Upgrade
|
| Minority Interest in Earnings | 39.73 | 74.86 | 93.52 | 127.34 | 100.12 | Upgrade
|
| Net Income | 6.82 | -46 | -60.64 | -86.58 | -64.7 | Upgrade
|
| Preferred Dividends & Other Adjustments | 8.7 | 9.89 | 8.03 | 8.03 | - | Upgrade
|
| Net Income to Common | -1.88 | -55.89 | -68.67 | -94.61 | -64.7 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 21 | 8 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 21 | 8 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 34.24% | 156.25% | 36.89% | 8.78% | 13.46% | Upgrade
|
| EPS (Basic) | -0.07 | -2.69 | -8.47 | -15.97 | -11.88 | Upgrade
|
| EPS (Diluted) | -0.07 | -2.69 | -8.47 | -15.97 | -11.88 | Upgrade
|
| Free Cash Flow | -65.78 | -80.19 | -128.29 | -182.12 | -121.11 | Upgrade
|
| Free Cash Flow Per Share | -2.36 | -3.86 | -15.82 | -30.74 | -22.23 | Upgrade
|
| Gross Margin | 48.11% | -34.82% | -52.60% | -118.70% | -133.97% | Upgrade
|
| Operating Margin | -111.00% | -184.98% | -160.99% | -268.76% | -260.21% | Upgrade
|
| Profit Margin | -2.97% | -96.91% | -81.25% | -124.91% | -94.06% | Upgrade
|
| Free Cash Flow Margin | -103.98% | -139.04% | -151.80% | -240.44% | -176.05% | Upgrade
|
| EBITDA | -65.56 | -102.22 | -130.06 | -196.18 | -173.9 | Upgrade
|
| EBITDA Margin | -103.63% | -177.24% | -153.89% | -259.00% | -252.79% | Upgrade
|
| D&A For EBITDA | 4.66 | 4.46 | 6 | 7.39 | 5.1 | Upgrade
|
| EBIT | -70.22 | -106.69 | -136.06 | -203.56 | -179 | Upgrade
|
| EBIT Margin | -111.00% | -184.98% | -160.99% | -268.76% | -260.21% | Upgrade
|
| Revenue as Reported | 63.26 | 57.68 | 84.51 | 75.74 | 68.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.